Swiss multinational pharmaceutical company (SIX: NOVN; NYSE: NVS). Focused on innovative medicines in oncology, cardiovascular, immunology, and neuroscience. $45bn revenue 2023. 78,000+ employees. Novartis Thailand manages innovative-medicines portfolio plus Novartis Access emerging-market programme.
← ← MNC Inclusion Index⬇ Download certificate (PDF)
Gold67/ 100
No 34 of 233 · gold
Novartis AG
67/100 · MNC Inclusion Index